Boothbay Fund Management, LLC Evolus, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 1,141,224 shares of EOLS stock, worth $11.2 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,141,224
Previous 1,287,767
11.38%
Holding current value
$11.2 Million
Previous $14.2 Million
3.43%
% of portfolio
0.42%
Previous 0.43%
Shares
17 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
52MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$49 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$40.5 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$39.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$35.8 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$31.7 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $550M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...